To determine the effects of the Wnt-β-catenin signaling on the expression of MRTF-A, breast cancer cells MCF-7 were treated with LiCl, an inhibitor of GSK-3β which phosphorylates β-catenin for the ubiquitination-mediated protein degradation. This evidence concerns the gene GSK3B and breast cancer.